The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Papillary

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Papillary


High impact information on Carcinoma, Papillary


Chemical compound and disease context of Carcinoma, Papillary


Biological context of Carcinoma, Papillary


Anatomical context of Carcinoma, Papillary


Gene context of Carcinoma, Papillary


Analytical, diagnostic and therapeutic context of Carcinoma, Papillary


  1. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Radvanyi, L., Singh-Sandhu, D., Gallichan, S., Lovitt, C., Pedyczak, A., Mallo, G., Gish, K., Kwok, K., Hanna, W., Zubovits, J., Armes, J., Venter, D., Hakimi, J., Shortreed, J., Donovan, M., Parrington, M., Dunn, P., Oomen, R., Tartaglia, J., Berinstein, N.L. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  2. Ret-mediated mitogenesis requires Src kinase activity. Melillo, R.M., Barone, M.V., Lupoli, G., Cirafici, A.M., Carlomagno, F., Visconti, R., Matoskova, B., Di Fiore, P.P., Vecchio, G., Fusco, A., Santoro, M. Cancer Res. (1999) [Pubmed]
  3. Progressive loss of CD44 gene expression in invasive bladder cancer. Sugino, T., Gorham, H., Yoshida, K., Bolodeoku, J., Nargund, V., Cranston, D., Goodison, S., Tarin, D. Am. J. Pathol. (1996) [Pubmed]
  4. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. Hwang, E.S., Kim, D.W., Hwang, J.H., Jung, H.S., Suh, J.M., Park, Y.J., Chung, H.K., Song, J.H., Park, K.C., Park, S.H., Yun, H.J., Kim, J.M., Shong, M. Mol. Endocrinol. (2004) [Pubmed]
  5. Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues. Porra, V., Bernier-Valentin, F., Trouttet-Masson, S., Berger-Dutrieux, N., Peix, J.L., Perrin, A., Selmi-Ruby, S., Rousset, B. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  6. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Grieco, M., Santoro, M., Berlingieri, M.T., Melillo, R.M., Donghi, R., Bongarzone, I., Pierotti, M.A., Della Porta, G., Fusco, A., Vecchio, G. Cell (1990) [Pubmed]
  7. A new mechanism of BRAF activation in human thyroid papillary carcinomas. Fusco, A., Viglietto, G., Santoro, M. J. Clin. Invest. (2005) [Pubmed]
  8. Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. Ciampi, R., Knauf, J.A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M.N., Rabes, H.M., Fagin, J.A., Nikiforov, Y.E. J. Clin. Invest. (2005) [Pubmed]
  9. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. Saito, T., Endo, T., Kawaguchi, A., Ikeda, M., Katoh, R., Kawaoi, A., Muramatsu, A., Onaya, T. J. Clin. Invest. (1998) [Pubmed]
  10. RET tyrosine kinase signaling in development and cancer. Arighi, E., Borrello, M.G., Sariola, H. Cytokine Growth Factor Rev. (2005) [Pubmed]
  11. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Moll, R., Wu, X.R., Lin, J.H., Sun, T.T. Am. J. Pathol. (1995) [Pubmed]
  12. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Higgins, J.P., Shinghal, R., Gill, H., Reese, J.H., Terris, M., Cohen, R.J., Fero, M., Pollack, J.R., van de Rijn, M., Brooks, J.D. Am. J. Pathol. (2003) [Pubmed]
  13. Normal iodide efflux from nonfunctioning nodules of human thyroid glands. Sherwin, J.R., Field, J.B. J. Clin. Endocrinol. Metab. (1978) [Pubmed]
  14. Ras oncogene mutations in benign and malignant thyroid neoplasms. Karga, H., Lee, J.K., Vickery, A.L., Thor, A., Gaz, R.D., Jameson, J.L. J. Clin. Endocrinol. Metab. (1991) [Pubmed]
  15. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. Herrmann, M.A., Hay, I.D., Bartelt, D.H., Ritland, S.R., Dahl, R.J., Grant, C.S., Jenkins, R.B. J. Clin. Invest. (1991) [Pubmed]
  16. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Powell, D.J., Russell, J., Nibu, K., Li, G., Rhee, E., Liao, M., Goldstein, M., Keane, W.M., Santoro, M., Fusco, A., Rothstein, J.L. Cancer Res. (1998) [Pubmed]
  17. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. Scarpino, S., Cancellario d'Alena, F., Di Napoli, A., Pasquini, A., Marzullo, A., Ruco, L.P. J. Pathol. (2004) [Pubmed]
  18. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Tanaka, T., Umeki, K., Yamamoto, I., Sakamoto, F., Noguchi, S., Ohtaki, S. Int. J. Cancer (1995) [Pubmed]
  19. Expression of Met protein in thyroid tumours. Ruco, L.P., Ranalli, T., Marzullo, A., Bianco, P., Prat, M., Comoglio, P.M., Baroni, C.D. J. Pathol. (1996) [Pubmed]
  20. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer. Santin, A.D., Diamandis, E.P., Bellone, S., Soosaipillai, A., Cane, S., Palmieri, M., Burnett, A., Roman, J.J., Pecorelli, S. Clin. Cancer Res. (2005) [Pubmed]
  21. Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. Shuja, S., Murnane, M.J. Int. J. Cancer (1996) [Pubmed]
  22. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Haber, R.S., Weiser, K.R., Pritsker, A., Reder, I., Burstein, D.E. Thyroid (1997) [Pubmed]
  23. Papillary carcinoma of the extrahepatic bile duct: characteristic features and implications in surgical treatment. Okamoto, A., Tsuruta, K., Matsumoto, G., Takahashi, T., Kamisawa, T., Egawa, N., Funata, N. J. Am. Coll. Surg. (2003) [Pubmed]
  24. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Gunningham, S.P., Currie, M.J., Han, C., Turner, K., Scott, P.A., Robinson, B.A., Harris, A.L., Fox, S.B. Cancer Res. (2001) [Pubmed]
  25. BRAF mutations in papillary carcinomas of the thyroid. Fukushima, T., Suzuki, S., Mashiko, M., Ohtake, T., Endo, Y., Takebayashi, Y., Sekikawa, K., Hagiwara, K., Takenoshita, S. Oncogene (2003) [Pubmed]
  26. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. Ishigaki, K., Namba, H., Nakashima, M., Nakayama, T., Mitsutake, N., Hayashi, T., Maeda, S., Ichinose, M., Kanematsu, T., Yamashita, S. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  27. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression. Tanaka, T., Umeki, K., Yamamoto, I., Sugiyama, S., Noguchi, S., Ohtaki, S. J. Pathol. (1996) [Pubmed]
  28. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. Scarpino, S., D'Alena, F.C., Di Napoli, A., Ballarini, F., Prat, M., Ruco, L.P. J. Pathol. (2003) [Pubmed]
  29. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Takano, T., Miyauchi, A., Yokozawa, T., Matsuzuka, F., Liu, G., Higashiyama, T., Morita, S., Kuma, K., Amino, N. Cancer Res. (1998) [Pubmed]
  30. E-cadherin: a differentiation marker in thyroid malignancies. Brabant, G., Hoang-Vu, C., Cetin, Y., Dralle, H., Scheumann, G., Mölne, J., Hansson, G., Jansson, S., Ericson, L.E., Nilsson, M. Cancer Res. (1993) [Pubmed]
  31. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Viglietto, G., Chiappetta, G., Martinez-Tello, F.J., Fukunaga, F.H., Tallini, G., Rigopoulou, D., Visconti, R., Mastro, A., Santoro, M., Fusco, A. Oncogene (1995) [Pubmed]
  32. Mucin production in metastatic papillary carcinoma of the thyroid. Chan, J.K., Tse, C.C. Hum. Pathol. (1988) [Pubmed]
  33. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. Oosterlinck, W., Kurth, K.H., Schröder, F., Bultinck, J., Hammond, B., Sylvester, R. J. Urol. (1993) [Pubmed]
WikiGenes - Universities